Core Insights - Vishay Intertechnology, Inc. (VSH) reported a second-quarter 2025 loss of 7 cents per share, missing the Zacks Consensus Estimate of earnings of 2 cents and down from earnings of 17 cents in the same quarter last year [1][7] - Revenues for the second quarter were $762.3 million, exceeding the Zacks Consensus Estimate by 0.3% and reflecting a year-over-year increase of 2.9% [1][7] Financial Performance - The company's weak second-quarter performance led to a 14.05% decline in share price, with a year-to-date drop of 17.8%, underperforming the Zacks Computer and Technology sector's growth of 10.9% [2] - VSH has a mixed earnings surprise history, missing the Zacks Consensus Estimate in three of the last four quarters, with an average negative surprise of 149.2% [2] Revenue Breakdown - Revenues from MOSFETs (19.5% of total revenues) were $148.6 million, down 4.19% year over year, with a book-to-bill ratio of 1.00 [3] - Diodes (19.4% of total revenues) generated $147.9 million, up 1.1% year over year, with a book-to-bill ratio of 0.93 [3] - Optoelectronics (7.1% of total revenues) revenues were $54.1 million, up 2.1% year over year, with a book-to-bill ratio of 1.05 [4] - Resistors (25.6% of total revenues) brought in $194.8 million, up 8.5% year over year, with a book-to-bill ratio of 0.91 [4] - Inductors (12.6% of total revenues) revenues were $95.7 million, up 1.7% year over year, with a book-to-bill ratio of 0.91 [4] - Capacitors (15.9% of total revenues) generated $121.1 million, up 6.8% year over year, with a book-to-bill ratio of 1.40 [5] Profitability Metrics - Adjusted EBITDA for the second quarter was $63.5 million, down 28.2% year over year, with an adjusted EBITDA margin of 8.3%, a contraction of 360 basis points [5][7] - The operating margin was reported at 2.9%, down from 5.1% in the year-ago quarter [5][7] Balance Sheet and Cash Flow - As of June 28, 2025, VSH's cash and cash equivalents were $473.9 million, down from $609.4 million as of March 29, 2025 [6] - Long-term debt decreased to $914.5 million from $988.2 million as of March 29 [6] - The company reported net cash used in operating activities of $8.8 million and a negative free cash flow of $73.2 million for the quarter [6] Guidance - For the third quarter, Vishay Intertechnology expects revenues of $775 million (plus or minus $20 million), with the Zacks Consensus Estimate for revenues at $752.4 million, indicating a year-over-year increase of 2.3% [8] - The anticipated gross profit margin is 19.7% (plus or minus 50 basis points), while the Zacks Consensus Estimate for earnings is 3 cents per share, reflecting a year-over-year decline of 62.5% [8]

2Q 2025 Earnings Conference Call August 6, 2025 © VISHAY INTERTECHNOLOGY, INC. ALL RIGHTS RESERVED. operating income determined in accordance with GAAP, adjusted for items that Management believes are not indicative of the intrinsic operating performance of the Company. The measurement is used by Management to evaluate our performance. Reconciling items to arrive at adjusted gross profit are also considered in the calculation of adjusted operating income; and reconciling items to arrive at adjusted operatin ...

Investment Rating - The report maintains a favorable outlook on the semiconductor industry, particularly favoring companies like Texas Instruments, Renesas, and Infineon [2][3]. Core Insights - The semiconductor inventory levels are showing signs of normalization, with MCU inventories stabilizing after a previous period of understocking [2][3]. - Pricing trends across various semiconductor categories have remained stable, with an average increase of 1% month-over-month and a 14% year-over-year increase [3][9]. - The report highlights a continued digestion of MCU inventories, which had previously been elevated, indicating a positive trend for the industry [3][12]. Summary by Relevant Sections Inventory Trends - MCU inventory has decreased by 1% month-over-month after a 5% decline in the previous month, while overall inventory levels were flat to down 2% across most categories [3][4]. - Capacitors and Sensors saw a month-over-month increase of 6% in inventory, contrasting with declines in other categories [4][15]. Pricing Trends - Pricing for MCUs remained flat month-over-month and increased by 1% year-over-year, while other categories experienced slight increases of 1-3% [4][15]. - The overall pricing environment is deemed manageable, with a year-over-year increase of 3% on a revenue exposure weighted basis [9][12]. Company Observations - The report notes that pricing for transistors increased by 1% month-over-month and 18% year-over-year, driven largely by bipolar transistors [4][15]. - Infineon has seen an increase in MCU inventory to 4% of the total, up from an average of 2.6%, indicating potential overstocking or market share gains [5][19].

Financial Data and Key Metrics Changes - In Q2 2025, the company reported revenue of $146 million, an increase of 8% year over year, and cash from operations of $36 million, both exceeding the high end of the guided range [8][14] - Earnings per share (EPS) for the quarter was $0.24, up 20% year over year [8][14] - Gross margins for the MedTech and Specialty Audio segment were 50.6%, down 280 basis points year over year, but improved 200 basis points sequentially [14][15] Business Line Data and Key Metrics Changes - MedTech and Specialty Audio revenue was $67 million, up 10% year over year, driven by increased demand in hearing health and specialty audio [9][14] - Precision Devices segment revenue was $79 million, up 6% year over year, with gross margins at 38.7%, an increase of 150 basis points from the previous year [10][16] Market Data and Key Metrics Changes - The primary end markets served, including medtech, defense, and industrial sectors, are expected to remain insulated from tariff impacts, with demand gaining strength [6][10] - Bookings trends in the Precision Device segment have shown positive growth for three consecutive quarters, indicating strong demand across various end markets [11][22] Company Strategy and Development Direction - The company is focused on leveraging unique technologies and creating custom products, aiming for organic growth acceleration in 2025 and beyond [12][13] - New product initiatives, such as the inductor line and specialty film production line, are expected to expand the total addressable market (TAM) and drive future growth [12][38] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the hearing health business and the overall strength of demand across segments, anticipating year-over-year growth for the full year 2025 [10][25] - The company is closely monitoring the industrial market, which has shown sensitivity to recessions but currently exhibits stable demand [6][10] Other Important Information - The company repurchased $30 million worth of shares in Q2, funded by strong cash generation from operations [12][18] - The net leverage ratio based on trailing twelve months adjusted EBITDA was 0.7x, with liquidity exceeding $350 million [18][42] Q&A Session Summary Question: What is providing the upside in guidance? - Management noted strong bookings in the Precision Device segment, with a book-to-bill ratio above 1.15, indicating broad-based demand across medical, defense, and industrial markets [22][25] Question: Any early thoughts on Q4? - While not providing specific guidance, management expects year-over-year and sequential growth in Q4 based on strong order activity [27][28] Question: Expectations for gross margin expansion? - Management anticipates gross margins to improve by at least 100 basis points in Q3, driven by capacity utilization in high-performance products [29] Question: Insights on M&A opportunities? - The M&A pipeline remains strong, with management being disciplined in pursuing opportunities that align with corporate strategy [39][40]

Investment Rating - The report maintains a positive outlook on the semiconductor industry, highlighting reassuring pricing trends and improving inventory levels [2][3]. Core Insights - The semiconductor market is experiencing a continued digestion of MCU inventory, with a 5% month-over-month decline and a 24% decrease compared to the previous month [3][4]. - Pricing across all product categories has remained stable, with an average increase of 1% month-over-month and 13% year-over-year [3][8]. - The report emphasizes the positive trends in pricing and inventory, particularly for companies like TI, Renesas, and Infineon, while also noting improvements for STM and other industrial MCU names [2][4]. Summary by Relevant Sections Inventory Trends - MCU inventory has decreased by 5% month-over-month, following a 4% decline the previous month, indicating a healthy destocking process [3][4]. - Other categories such as Sensors and Diodes also saw inventory reductions of 5% and 4% respectively, while overall inventory trends are generally stable [3][4]. Pricing Trends - Pricing for MCUs remained flat month-over-month and year-over-year, while transistors saw a 2% increase month-over-month and a 17% increase year-over-year [4][14]. - Capacitors, Diodes, and Sensors experienced price increases of 2-3%, contributing to an overall stable pricing environment [4][14]. Company Observations - Infineon and STM showed varied pricing trends, with Infineon down 4% and STM up 4% in June compared to May, reflecting a mix-driven pricing environment [5][8]. - The report indicates that inventory levels are stable, with significant destocking in MCUs, previously driven by MCHP and now also by STM [5][11].

Core Viewpoint - Vishay Intertechnology, Inc. reported a first-quarter 2025 loss of 3 cents per share, which met the Zacks Consensus Estimate but was a decline from the previous year's earnings of 22 cents per share. Revenues of $715.2 million exceeded the Zacks Consensus Estimate by 0.74%, but represented a 4.2% year-over-year decline [1][2]. Financial Performance - The company's first-quarter adjusted EBITDA was $54.5 million, a decrease of 40.3% year over year, with an adjusted EBITDA margin contracting by 460 basis points to 7.6%. The operating margin fell to 0.1% from 5.7% in the year-ago quarter [6]. - Revenues from various segments showed mixed results: - MOSFETs generated $142.1 million, down 7.2% year over year [4]. - Diodes brought in $141 million, declining 5.4% year over year [4]. - Optoelectronics revenues increased by 4.1% to $51.2 million [4]. - Resistors fell 4.6% to $179.5 million [5]. - Inductors decreased by 5.2% to $84.1 million [5]. - Capacitors saw a slight decline of 0.4% to $117.4 million [5]. Stock Performance - The weak first-quarter performance led to a 9.8% drop in the company's share price, with a year-to-date decline of 28.4%, significantly underperforming the Zacks Computer and Technology sector's decline of 8.7% [2]. Guidance - For the second quarter, Vishay Intertechnology anticipates revenues of $760 million (plus or minus $20 million), with a Zacks Consensus Estimate of $738.4 million, indicating a year-over-year fall of 0.38%. The expected gross profit margin is 19.0% [9].

Financial Performance - 1Q 2025 revenues reached $715.2 million[25], slightly above 4Q 2024's $714.7 million[26] but lower than 1Q 2024's $746.3 million[26] - Gross margin was 19.0%[25], including a negative impact of approximately 200 bps related to Newport[25] - The company reported a loss per share (EPS) of $(0.03)[25] and an adjusted EPS of $(0.03)[25] - Adjusted EBITDA margin was 7.6%[27] Book-to-Bill Ratio - Overall book-to-bill ratio was 1.08[25] - Semiconductors had a book-to-bill ratio of 1.12[25] - Passive components had a book-to-bill ratio of 1.04[25] Revenue Mix by End Market - Industrial sector accounted for 34% of revenue in 1Q25[17], showing a 3% QoQ increase and a 1% YoY decrease[16] - Automotive sector represented 33% of revenue in 1Q25[17], with a 2% QoQ increase and an 11% YoY increase[16] - Other sectors contributed 14% of revenue in 1Q25[17], showing a 4% QoQ increase and an 8% YoY increase[16] - Aero/Defense sector accounted for 11% of revenue in 1Q25[17], with a -5% QoQ decrease and an 8% YoY increase[16] - Medical sector accounted for 5% of revenue in 1Q25[17], with a -1% QoQ decrease and a +6% YoY increase[16] Revenue Mix by Region - Europe accounted for 36% of revenue in 1Q25[23], showing an 8% QoQ increase and a -6% YoY decrease[22] - Asia accounted for 40% of revenue in 1Q25[23], with a -3% QoQ decrease and a 0% YoY change[22] - Americas accounted for 24% of revenue in 1Q25[23], with a -6% QoQ decrease and a -8% YoY decrease[22] Guidance for 2Q 2025 - Revenue is expected to be $760 million, with a +/- $20 million range[48], representing an approximate 1% to 2% increase versus 1Q[46] - Gross margin is projected at 19.0% +/- 50 bps[48], with a negative impact of 175-200 bps from Newport[48]

Financial Data and Key Metrics Changes - The company reported Q1 2025 revenue of $132 million, at the high end of the guided range, with EPS of $0.18, also at the midpoint of guidance [11][18] - Gross margins for Q1 were 48.7%, down 450 basis points year-over-year, primarily due to a supply agreement impacting margins and unfavorable customer mix [18] - Cash from operations exceeded the high end of the guided range, driven by higher than expected customer prepayments [20][21] Business Line Data and Key Metrics Changes - MedTech and Specialty Audio revenue was $60 million, slightly up year-over-year but seasonally down from Q4 [11][18] - Precision Device segment revenues were $73 million, flat compared to Q4, with gross margins at 35.7%, flat year-over-year [12][18] - The company expects year-over-year revenue growth to accelerate in Q2 2025, driven by strong demand in MedTech and Specialty Audio [12][16] Market Data and Key Metrics Changes - The company estimates that less than 5% of revenue is subject to current tariffs, with less than 3% of cost of goods sold impacted [6][8] - Inventory levels at distributors are normalizing, leading to increased order activity, particularly in the industrial market [33][52] Company Strategy and Development Direction - The company is focused on growth in 2025, with expectations for year-over-year revenue growth and strong cash generation [15][24] - The management highlighted the importance of partnerships with customers to drive innovation and performance enhancements in products [12][16] - The company plans to explore acquisition opportunities and maintain manageable debt levels while investing in capacity expansion [14][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to grow despite the current tariff environment, citing essential nature of products in MedTech and defense sectors [4][10] - The company is monitoring the macroeconomic environment closely, particularly in the industrial market, but currently sees no significant impact on demand [10][33] - Management anticipates a stronger second half of 2025, driven by increasing order activity and a growing backlog [39][40] Other Important Information - The company repurchased $5 million in shares and reduced debt by $15 million during Q1 [14][21] - The company expects capital spending to be 5% of revenues as it increases investments in capacity expansion related to the specialty film line [23] Q&A Session Summary Question: Can you discuss overall end market customer exposure and outlook? - Management noted no change in demand and higher expectations for Q2 compared to the previous quarter, emphasizing the essential nature of products in MedTech and defense [30][32] Question: Any updates on the $75 million capacitor order for the energy market? - Management confirmed a substantial prepayment received in Q1, indicating strong customer commitment and no expected impact on delivery starting in 2026 [35] Question: Can you provide insights on gross margin trajectory for Q2 and Q4? - Management expects significant sequential improvement in gross margins, driven by increased capacity utilization and better customer mix [38][39] Question: Are there opportunities for market share gain from competitors? - Management acknowledged receiving inquiries from customers considering switching suppliers due to tariff impacts, particularly in the industrial space [45][46] Question: Can you comment on bookings and receivables? - Management reported strong bookings trends and noted that receivables were up due to timing of customer payments, with no collection issues [49][55]

Financial Data and Key Metrics Changes - The company reported Q1 2025 revenue of $132 million, at the high end of the guided range, with EPS of $0.18, also at the midpoint of guidance [11][19] - Gross margins for the MedTech and Specialty Audio segment were 48.7%, down 450 basis points year-over-year, primarily due to a supply agreement impacting margins [19] - Precision Devices segment revenues were $73 million, flat compared to Q4, with gross margins at 35.7%, unchanged from the previous year [13][20] Business Line Data and Key Metrics Changes - MedTech and Specialty Audio revenue was $60 million, slightly up year-over-year but seasonally down from Q4 [11][19] - Precision Devices segment saw a flat revenue performance, with production challenges in the specialty film line being addressed [13][20] - The company expects year-over-year revenue growth to accelerate in Q2 2025, driven by strong demand in MedTech and Specialty Audio [12][17] Market Data and Key Metrics Changes - The company estimates that less than 5% of revenue is subject to current tariffs, with less than 3% of cost of goods sold impacted [7][8] - Inventory levels at distributors have normalized to 3-3.5 months, indicating increased order activity [34][52] - The company is seeing strong bookings trends across most end markets, particularly in Precision Devices [15][52] Company Strategy and Development Direction - The company is focused on growth in 2025, with strong design wins and increasing backlog across its product portfolio [17] - There is an emphasis on exploring acquisition opportunities while maintaining manageable debt levels [16][22] - The upcoming Investor Day will detail future growth plans and competitive advantages [17][60] Management's Comments on Operating Environment and Future Outlook - Management remains cautious about the tariff environment but believes the company is well-positioned for growth despite potential impacts [5][10] - The outlook for the MedTech and defense sectors remains strong, with essential devices expected to maintain demand [32][33] - Management anticipates a stronger second half of 2025, driven by improved capacity utilization and demand recovery [41][42] Other Important Information - The company repurchased $5 million in shares and reduced debt by $15 million in Q1 2025 [16][22] - Capital spending is projected to be $7 million in Q2, with full-year capital spending expected to be 5% of revenues [24] Q&A Session Summary Question: Overall end market customer exposure and outlook - Management indicated no change in demand and higher expectations for Q2, particularly in essential devices like pacemakers and hearing aids [31][32] Question: Updates on the $75 million capacitor order - A substantial prepayment was received, indicating strong customer commitment with no expected delivery impacts [37] Question: Gross margin trajectory for Q2 and Q4 - Management expects significant sequential improvement in gross margins, projecting an exit range of 45% to 47% by year-end [40][44] Question: Potential for gaining market share from competitors - Management noted increased inquiries from customers considering switching suppliers due to tariff impacts, particularly in the industrial space [46][47] Question: Commentary on bookings and receivables - Bookings were strong, with inventory levels at distributors decreasing, indicating rising demand [52][56]